- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears Toshiba’s Latest Aquilion CT
The Aquilion Prime 80 features the AIDR 3D dose reduction software.
Toshiba America Medical Systems Inc. has received FDA clearance for the latest in its Aquilion CT product line, the Aquilion Prime 80 series, the company announced Monday.
The system, which features their Adaptive Iterative Dose Reduction 3D software, can generate 80 unique slices per rotation and is designed with in-field upgradeability to 160 slices, the company said.
The Aquilion Prime features a 0.5 mm detector, a 7.5 MHU large-capacity tube and 0.35 second scanning. The system also includes a 78 cm aperture gantry and a 660-pound patient-weight-capacity couch. In addition to the AIDR 3D software, the system comes with Nema XR 25 Dose Check Software which includes dose alert and notification features.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
